In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1 (Z1)
In Vivo Clinical Investigation of the Safety and Performance of Dental Implants TBR® Tissue Level Z1 With Ceramic Emergence
Sponsor: Sudimplant SAS - Groupe TBR
Listed as NCT04984499, this observational or N/A phase trial focuses on Edentulous Mouth and remains ongoing. Sponsored by Sudimplant SAS - Groupe TBR, it has been updated 6 times since 2021, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Dec 2022 — May 2024 [monthly]
Recruiting
-
Jun 2022 — Dec 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Sep 2021 — Jun 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sudimplant SAS - Groupe TBR
For direct contact, visit the study record on ClinicalTrials.gov .